Physician profile
James Thompson Mcclain
NPI 1528320918
$23,853.14
in general payments reported to CMS, 2019-2025
91 companies · $4,893 in 2025
The $4,893 reported for 2025 was more than what 82% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,545 · 2020: $1,978 · 2021: $3,378 · 2022: $3,161 · 2023: $3,895 · 2024: $5,004 · 2025: $4,893.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $12K · Long Term Medical Supply Or Device Loan: $698 · Education: $670.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,424.40 |
| Long Term Medical Supply Or Device Loan | $697.90 |
| Education | $670.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,403.57 | 2019-2025 | |
| Janssen Biotech, INC. | $1,543.70 | 2019-2025 | Darzalex, Tecvayli, Rybrevant |
| Astrazeneca Pharmaceuticals LP | $1,193.99 | 2019-2025 | Calquence, Tagrisso, Enhertu |
| Daiichi Sankyo INC. | $982.01 | 2019-2025 | Enhertu, Injectafer, Datroway |
| Seagen INC. | $933.98 | 2019-2023 | Padcev, Tukysa, Adcetris |
| Merck Sharp & Dohme LLC | $911.12 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Eisai INC. | $882.97 | 2019-2025 | |
| Pfizer INC. | $873.79 | 2019-2025 | |
| Astellas Pharma US INC | $853.29 | 2019-2025 | Padcev, Vyloy, Xtandi |
| Celgene Corporation | $775.42 | 2019-2025 | Reblozyl, Opdualag, Pomalyst |
| Bayer Healthcare Pharmaceuticals INC. | $738.76 | 2019-2025 | |
| Incyte Corporation | $701.95 | 2019-2025 | Monjuvi, Jakafi, Pemazyre |
| Amgen INC. | $687.60 | 2019-2024 | Lumakras, Vectibix, Xgeva |
| Genentech USA, INC. | $648.20 | 2019-2025 | Venclexta, Tecentriq, Phesgo |
| E.R. Squibb & Sons, L.L.C. | $593.78 | 2019-2025 | Opdualag, Opdivo |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Gilead Sciences, INC. | $568.24 | 2021-2025 | Trodelvy |
| Exelixis INC. | $534.56 | 2019-2025 | Cabometyx |
| Genzyme Corporation | $440.52 | 2019-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $415.87 | 2019-2025 | Ninlaro, Alunbrig, Fruzaqla |
| Abbvie INC. | $361.75 | 2021-2025 | |
| Lilly USA, LLC | $354.85 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Glaxosmithkline, LLC. | $301.63 | 2020-2025 | Ojjaara, Jemperli, Zejula |
| Regeneron Healthcare Solutions, INC. | $287.42 | 2019-2025 | Libtayo |
| Ipsen Biopharmaceuticals, INC | $283.72 | 2019-2025 | Onivyde, Somatuline Depot, Tazverik |
| Emd Serono, INC. | $270.70 | 2019-2025 | Bavencio |
| Acrotech Biopharma INC. | $263.53 | 2021-2025 | Beleodaq |
| Beigene USA, INC. | $218.11 | 2020-2025 | Brukinsa |
| Coherus Oncology, INC. | $216.45 | 2020-2025 | Loqtorzi |
| Taiho Oncology, INC. | $204.90 | 2020-2025 | |
| Jazz Pharmaceuticals INC. | $203.54 | 2020-2025 | |
| Alnylam Pharmaceuticals INC. | $200.36 | 2022-2025 | Givlaari |
| Kite Pharma, INC. | $189.12 | 2020-2023 | |
| Rigel Pharmaceuticals, INC. | $181.29 | 2020-2025 | Rezlidhia, Tavalisse, Gavreto |
| Boehringer Ingelheim Pharmaceuticals, INC. | $170.08 | 2021-2025 | Gilotrif |
| Genentech, INC. | $159.80 | 2019 | |
| Array Biopharma INC | $132.78 | 2022-2025 | Mektovi, Braftovi, Lorbrena |
| Aveo Pharmaceuticals, INC. | $129.69 | 2021-2025 | Fotivda |
| Pharmacosmos Therapeutics INC. | $126.23 | 2021-2025 | Cosela, Monoferric |
| Stemline Therapeutics INC. | $125.65 | 2023-2025 | Orserdu |
| Karyopharm Therapeutics INC. | $124.17 | 2020-2025 | Xpovio |
| Kyowa Kirin, INC. | $122.33 | 2021-2025 | Poteligeo |
| Servier Pharmaceuticals LLC | $114.35 | 2021-2024 | |
| Adaptive Biotechnologies Corporation | $110.80 | 2022-2024 | Clonoseq |
| Pharmacyclics LLC, An Abbvie Company | $109.98 | 2019-2022 | |
| Beone Medicines USA, INC. | $105.91 | 2025 | Brukinsa |
| Galvanize Therapeutics, INC | $98.10 | 2025 | Aliya System |
| Alexion Pharmaceuticals, INC. | $95.41 | 2021-2022 | |
| Global Blood Therapeutics, INC. | $91.85 | 2021-2022 | |
| G1 Therapeutics, INC. | $88.23 | 2022-2023 | Cosela |
| Tersera Therapeutics LLC | $87.95 | 2022-2025 | Xermelo |
| Sanofi-Aventis U.S. LLC | $84.99 | 2023 | |
| Blueprint Medicines Corporation | $81.27 | 2021-2024 | Ayvakit |
| Deciphera Pharmaceuticals INC. | $80.99 | 2021-2024 | Qinlock |
| Mirati Therapeutics, INC. | $79.64 | 2023 | Krazati |
| Adc Therapeutics America, INC. | $73.63 | 2023-2025 | |
| Pharmaessentia USA Corporation | $68.35 | 2022-2025 | Besremi |
| Springworks Therapeutics, INC. | $62.45 | 2024-2025 | Ogsiveo, Gomekli |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $62.25 | 2023-2024 | Relistor |
| Azurity Pharmaceuticals, INC. | $61.46 | 2025 | Danziten |
| Epizyme, INC. | $59.89 | 2020-2022 | |
| Sumitomo Pharma America, INC. | $57.29 | 2023 | Orgovyx |
| Novocure INC. | $55.61 | 2020-2024 | Optune, Optune Lua (Novottf-200t) |
| Accord Healthcare, INC. | $49.86 | 2023-2025 | |
| Tactile Systems Technology INC | $48.22 | 2021-2025 | Flexitouch Plus, Nimbl |
| Secura Bio, INC. | $47.35 | 2019-2020 | |
| Advanced Accelerator Applications | $46.85 | 2020 | |
| Dova Pharmaceuticals | $45.37 | 2019-2021 | |
| Agios Pharmaceuticals, INC. | $43.85 | 2024 | Pyrukynd |
| Sobi, INC | $42.73 | 2023-2024 | |
| Genmab U.S., INC. | $41.08 | 2024-2025 | Tivdak |
| Foundation Medicine, INC. | $40.63 | 2020-2022 | |
| Spectrum Pharmaceuticals INC. | $34.25 | 2023-2025 | Rolvedon |
| Puma Biotechnology, INC. | $34.02 | 2021-2025 | |
| Clovis Oncology, INC. | $32.24 | 2020 | |
| Heron Therapeutics, INC. | $31.64 | 2019-2021 | |
| Caris Mpi, INC. | $23.58 | 2025 | Mi Cancer Seek |
| Organon LLC | $21.85 | 2021 | |
| Geron Corporation | $19.58 | 2025 | Rytelo |
| Sun Pharmaceutical Industries INC. | $19.48 | 2023 | Odomzo, Yonsa |
| Teva Pharmaceuticals USA, INC. | $18.47 | 2020 | |
| Myriad Genetic Laboratories, INC. | $18.42 | 2021 | |
| Iovance Biotherapeutics, INC. | $18.12 | 2025 | Amtagvi |
| Recordati_rare_diseases_inc. | $17.89 | 2023 | Sylvant |
| Sandoz INC. | $17.48 | 2021 | |
| Progenics Pharmaceuticals, INC. | $16.98 | 2024 | |
| Morphosys, US INC. | $16.14 | 2021 | |
| Blue Earth Diagnostics | $14.58 | 2022 | |
| Tg Therapeutics, INC. | $14.51 | 2022 | |
| Verastem, INC. | $12.91 | 2019 | |
| Mylan Institutional INC. | $11.97 | 2020 | |
| Amag Pharmaceuticals, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
Kisqali $984Enhertu $731Lenvima $545Nubeqa $512Xofigo $503Keytruda $429Darzalex $420Padcev $410Cabometyx $335Reblozyl $319Tecvayli $317Xtandi $285Rybrevant $256Brukinsa $242Scemblix $233Tukysa $230Venclexta $227Talzenna $219Opdualag $211Imbruvica $209Lynparza $200Erleada $198Ibrance $188Jaypirca $182Beleodaq $177Jevtana $175Givlaari $175Talvey $175Orgovyx $165Welireg $165Verzenio $161Fabhalta $156Calquence $154Tagrisso $153Monjuvi $147Adcetris $135Sarclisa $130Orserdu $126Libtayo $119Trodelvy $115Ninlaro $109Lonsurf $108Inqovi $108Promacta $108Tavalisse $106Rezlidhia $106Jakafi $105Injectafer $103Elrexfio $103Ojjaara $101Retevmo $98.43Aliya System $98.10Pemazyre $97.16Mektovi $96.76Opdivo $95.90Alunbrig $94.44Inlyta $92.48Braftovi $91.79Jemperli $90.33Zejula $90.33Lorbrena $86.53Relistor $84.26Poteligeo $80.40Krazati $79.64Zepzelca $79.12Fruzaqla $78.03Fotivda $75.82Zynyz $74.24Onivyde $72.52Lutathera $68.20Xermelo $67.05Tecentriq $65.50Danziten $61.46Emrelis $60.14Phesgo $59.31Pomalyst $58.75Qinlock $58.40Tibsovo $55.55Xpovio $53.90Polivy $53.84Keytruda Qlex $52.65Bavencio $52.25Vyloy $51.97Piqray $51.87Somatuline Depot $51.06Gilotrif $50.46Camcevi $49.86Cosela $49.80Besremi $49.36Lupron Depot $43.72Clonoseq $43.35Doptelet $42.73Tivdak $41.08Gavreto $39.80Udenyca $38.62Ayvakit $38.43Lumakras $38.18Zynlonta $38.06Tasigna $36.97Ogsiveo $36.41
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Mcclain listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.